Research News Cystic fibrosis: triple therapy shows promising results BMJ 2019; 367 doi: https://doi.org/10.1136/bmj.l6347 (Published 04 November 2019) Cite this as: BMJ 2019;367:l6347 Article Related content Metrics Responses Peer review Related articles News Cystic fibrosis drugs to be available on NHS in England within 30 days Published: 24 October 2019; BMJ 367 doi:10.1136/bmj.l6206 See more Tuberculosis: WHO warns of “crippling breakdowns” in response after funding cuts BMJ March 21, 2025, 388 r577; DOI: https://doi.org/10.1136/bmj.r577 Mpox in Uganda is now responsible for 40% of Africa’s new cases BMJ March 18, 2025, 388 r548; DOI: https://doi.org/10.1136/bmj.r548 Respiratory health: Follow guidelines to reduce repeat hospital visits, urge campaigners BMJ March 18, 2025, 388 r545; DOI: https://doi.org/10.1136/bmj.r545 Winter viruses: we can do more to prevent a surge in cases BMJ January 15, 2025, 388 r77; DOI: https://doi.org/10.1136/bmj.r77 Winter pressure: NHS struggles to cope with flu surge as hospitals declare critical incidents BMJ January 10, 2025, 388 r51; DOI: https://doi.org/10.1136/bmj.r51 Cited by... Longitudinal Profiling of the Intestinal Microbiome in Children with Cystic Fibrosis Treated with Elexacaftor-Tezacaftor-IvacaftorAbstract Fulltext PDF
